The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Cyclosarin     (fluoro-methyl- phosphoryl)oxycyclohexane

Synonyms: AGN-PC-0016KP, CMPF ester, GF cpd, CF Me ester, AC1Q6RFO, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Cyclohexyl methylphosphonofluoridate

  • Data from inhibition of acetylcholinesterase, in vivo toxicity tests of a representative analogue (cyclosarin), and kinetic studies with phosphotriesterase (PTE) from Pseudomonas diminuta, and a mammalian serum paraoxonase (PON1), confirmed that the analogues mimic the parent nerve agents effectively [1].
  • Inhalation toxicity of Cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: potency comparison to sarin (GB) [2].
  • The current studies estimated effective (miosis) concentrations of the nerve agents' sarin (GB) and cyclosarin (GF) as a function of exposure duration in the Gottingen minipig and determined dependency of the median effective dosage (ECT50) over time [3].
  • Thus, the oxime HI-6 seems to be the most suitable oxime for the antidotal treatment of acute poisonings with Russian VX as in the case of VX, sarin, cyclosarin, and soman poisonings [4].
 

High impact information on Cyclohexyl methylphosphonofluoridate

  • Two guinea pig models were used to study the anticonvulsant potency of diazepam, midazolam, and scopolamine against seizures induced by the nerve agents tabun, sarin, soman, cyclosarin, O-ethyl S-(2-(diisopropylamino)ethyl)methylphosphonothioate (VX), and O-isobutyl S-(2-diethylamino)ethyl)-methyl phosphonothioate (VR) [5].
  • The greatest inhibition was observed for the O-cyclohexyl methylphosphonyl-2PAM derivative (4.0 x 10(9)M(-1)min(-1); mouse AChE) and is 10-fold higher than the k(i) of cyclosarin [6].
  • Effects of low-level inhalation exposure to cyclosarin on learned behaviors in Sprague-Dawley rats [7].
  • Mortality dose-response curves for several OP compounds (i.e., VX, soman, cyclosarin, sarin, tabun, diisopropylfluorophosphate and paraoxon) exhibited steep probit slopes (> 9.6) in guinea pigs [8].
  • On the other hand, only HI-6 is able to reactivate satisfactorily cyclosarin-inhibited AChE [9].
 

Chemical compound and disease context of Cyclohexyl methylphosphonofluoridate

 

Biological context of Cyclohexyl methylphosphonofluoridate

 

Anatomical context of Cyclohexyl methylphosphonofluoridate

  • The reactivating properties of the two salts were compared on human erythrocyte AChE inhibited with paraoxon, sarin, cyclosarin and agent VX [16].
 

Associations of Cyclohexyl methylphosphonofluoridate with other chemical compounds

 

Gene context of Cyclohexyl methylphosphonofluoridate

  • GC/pulsed flame photometer detector analysis, compared with assay of residual acetylcholinesterase inhibition, displayed stereoselective hydrolysis of cyclosarin, soman, and IMP-pNP, indicating that PON1 is less active toward the more toxic optical isomers [13].
  • K033 is sufficient reactivator of cyclosarin-inhibited AChE [21].
 

Analytical, diagnostic and therapeutic context of Cyclohexyl methylphosphonofluoridate

  • Cyclosarin caused a marked statistically significant change in most of the neurobehavioral parameters (FOB) at 24 h and 7 days after exposure, compared to the saline control group [22].

References

  1. Analogues with fluorescent leaving groups for screening and selection of enzymes that efficiently hydrolyze organophosphorus nerve agents. Briseño-Roa, L., Hill, J., Notman, S., Sellers, D., Smith, A.P., Timperley, C.M., Wetherell, J., Williams, N.H., Williams, G.R., Fersht, A.R., Griffiths, A.D. J. Med. Chem. (2006) [Pubmed]
  2. Inhalation toxicity of Cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: potency comparison to sarin (GB). Anthony, J.S., Haley, M., Manthei, J., Way, R., Burnett, D., Gaviola, B., Sommerville, D., Crosier, R., Mioduszewski, R., Thomson, S., Crouse, C., Matson, K. Inhalation toxicology. (2004) [Pubmed]
  3. Comparison of low-level sarin and cyclosarin vapor exposure on pupil size of the gottingen minipig: effects of exposure concentration and duration. Hulet, S.W., Sommerville, D.R., Crosier, R.B., Dabisch, P.A., Miller, D.B., Benton, B.J., Forster, J.S., Scotto, J.A., Jarvis, J.R., Krauthauser, C., Muse, W.T., Reutter, S.A., Mioduszewski, R.J., Thomson, S.A. Inhalation toxicology. (2006) [Pubmed]
  4. The Reactivating and Therapeutic Efficacy of Oximes to Counteract Russian VX Poisonings. Kassa, J., Jun, D., Kuca, K. International journal of toxicology. (2006) [Pubmed]
  5. Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine. Shih, T.M., Rowland, T.C., McDonough, J.H. J. Pharmacol. Exp. Ther. (2007) [Pubmed]
  6. Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators. Ashani, Y., Bhattacharjee, A.K., Leader, H., Saxena, A., Doctor, B.P. Biochem. Pharmacol. (2003) [Pubmed]
  7. Effects of low-level inhalation exposure to cyclosarin on learned behaviors in Sprague-Dawley rats. Genovese, R.F., Benton, B.J., Shippee, S.J., Jakubowski, E.M., Bonnell, J.C. J. Toxicol. Environ. Health Part A (2006) [Pubmed]
  8. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds? Maxwell, D.M., Brecht, K.M., Koplovitz, I., Sweeney, R.E. Arch. Toxicol. (2006) [Pubmed]
  9. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions. Kuca, K., Cabal, J., Jun, D., Kassa, J., Bartosová, L., Kunesová, G. Journal of applied toxicology : JAT. (2005) [Pubmed]
  10. The acute toxicity of acetylcholinesterase reactivators in mice in relation to their structure. Bartosova, L., Kuca, K., Kunesova, G., Jun, D. Neurotoxicity research. (2006) [Pubmed]
  11. Therapeutic efficacy of different antidotal mixtures against poisoning with GF-agent in mice. Bartosová, L., Kunesová, G., Kuca, K., Vachek, J. Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové. (2004) [Pubmed]
  12. Toxicity of organophosphate nerve agents and related phosphonylated oximes compared to their anticholinesterase activity in neuron cultures. Sawyer, T.W., Weiss, M.T., Boulet, C.A., Hansen, A.S. Fundamental and applied toxicology : official journal of the Society of Toxicology. (1991) [Pubmed]
  13. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase. Amitai, G., Gaidukov, L., Adani, R., Yishay, S., Yacov, G., Kushnir, M., Teitlboim, S., Lindenbaum, M., Bel, P., Khersonsky, O., Tawfik, D.S., Meshulam, H. FEBS J. (2006) [Pubmed]
  14. Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases. Worek, F., Eyer, P., Szinicz, L. Arch. Toxicol. (1998) [Pubmed]
  15. Generation, sampling, and analysis for low-level GB (Sarin) and GF (Cyclosarin) vapor for inhalation toxicology studies. Muse, W.T., Thomson, S., Crouse, C., Matson, K. Inhalation toxicology. (2006) [Pubmed]
  16. Equipotent cholinesterase reactivation in vitro by the nerve agent antidotes HI 6 dichloride and HI 6 dimethanesulfonate. Krummer, S., Thiermann, H., Worek, F., Eyer, P. Arch. Toxicol. (2002) [Pubmed]
  17. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Worek, F., Widmann, R., Knopff, O., Szinicz, L. Arch. Toxicol. (1998) [Pubmed]
  18. Efficacy of various oximes against GF (cyclohexyl methylphosphonofluoridate) poisoning in mice. Clement, J.G. Arch. Toxicol. (1992) [Pubmed]
  19. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Kuca, K., Cabal, J., Kassa, J. Die Pharmazie. (2004) [Pubmed]
  20. Structural requirements of acetylcholinesterase reactivators. Kuca, K., Juna, D., Musilek, K. Mini reviews in medicinal chemistry. (2006) [Pubmed]
  21. Comparison of the potency of newly developed and currently available oximes to reactivate nerve agent-inhibited acetylcholinesterase in vitro and in vivo. Kuca, K., Bartosova, L., Kassa, J., Cabal, J., Bajgar, J., Kunesova, G., Jun, D. Chem. Biol. Interact. (2005) [Pubmed]
  22. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators. Krejcova-Kunesova, G., Bartosova, L., Kuca, K. Toxicology (2005) [Pubmed]
 
WikiGenes - Universities